Comparing Physical Container Closure Integrity Test Methods and Artificial Leak Methodologies

References

1. 1.↵
   U.S. Pharmacopeial Convention, General Chapter <1207> Package Integrity Evaluation - Sterile Products. In USP 39-NF 34, USP: Rockville, MD, 2016; pp 1700–1707.
2. 2.↵
   1. Mahler H. C.,
   2. Friess W.,
   3. Grauschopf U,
   4. Kiese S.

   Protein aggregation: pathways, induction factors and analysis. J. Pharm. Sci. 2009, 98 (9), 2909–2934.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Pikal M. J.,
   2. Dellerman K.,
   3. Roy M. L.

   Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Dev. Biol. Stand. 1992, 74, 21–37; discussion 37–38.

   OpenUrlPubMed
4. 4.↵
   European Commission, EudraLex-The Rules Governing Medicinal Products in the European Union, Volume 4: EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, Annex 1: Manufacture of Sterile Medicinal Products. European Commission: Brussels, 2008.
5. 5.↵
   U.S. Pharmacopeial Convention, General Chapter <1207.1> Package Integrity Testing in the Product Life Cycle -Test Method Selection and Validation. In USP 39–NF 34, USP: Rockville, MD, 2016; pp 1707–1719.
6. 6.↵
   1. Brown H.,
   2. Mahler H. C.,
   3. Mellman J.,
   4. Nieto A.,
   5. Wagner D.,
   6. Schaar M.,
   7. Mathaes R.,
   8. Kossinna J.,
   9. Schmitting F.,
   10. Dreher S.,
   11. Roehl H.,
   12. Hemminger M.,
   13. Wuchner K.

   Container Closure Integrity Testing-Practical Aspects and Approaches in the Pharmaceutical Industry. PDA J. Pharm. Sci. Technol. 2017, 71 (2), 147–162.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Kolhe P.,
   2. Shah M.,
   3. Rathore N.

   1. Li L.

   Advances in Container Closure Integrity Testing. In Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations, Kolhe P., Shah M., Rathore N., Eds. Springer: New York, 2013; pp 315–329.
8. 8.↵
   1. Burrell L. S.,
   2. Carver M. W.,
   3. DeMuth G. E.,
   4. Lambert W. J.

   Development of a Dye Ingress Method to Assess Container-Closure Integrity: Correlation to Microbial Ingress. PDA J. Pharm. Sci. Technol. 2000, 54 (6), 449–455.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Wolf H.,
   2. Stauffer T.,
   3. Chen S. C.,
   4. Lee Y.,
   5. Forster R.,
   6. Ludzinski M.,
   7. Kamat M.,
   8. Godorov P.,
   9. Guazzo D. M.

   Vacuum decay container/closure integrity testing technology. Part 1. ASTM F2338–09 precision and bias studies. PDA J. Pharm. Sci. Technol. 2009, 63 (5), 472–488.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Sudo H.,
    2. O'Driscoll M.,
    3. Nishiwaki K.,
    4. Kawamoto Y.,
    5. Gammell P.,
    6. Schramm G.,
    7. Wertli T.,
    8. Prinz H.,
    9. Mori A.,
    10. Sako K.

    Development of a nondestructive leak testing method utilizing the head space analyzer for ampoule products containing ethanol-based solutions. PDA J. Pharm. Sci. Technol. 2012, 66 (5), 434–444.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Veale J. R.,
    2. Victor K. G.

    Oxygen Permeation Rates Through Syringe Components; Lighthouse Instruments, LLC: Charlottesville, VA, Published Online Nov 28, 2016: https://biopharma-asia.com/technical-papers/oxygen-permeation-rates-through-syringe-components/ (accessed November 10, 2017).
12. 12.↵
    1. Wertli A.

    Method for leak testing closed, at least partially gas filled containers. EP2449356A1/US9891132B2, 2018.
13. 13.↵
    1. Kirsch L. E.,
    2. Nguyen L.,
    3. Moeckly C. S.

    Pharmaceutical container/closure integrity. I: Mass spectrometry-based helium leak rate detection for rubber-stoppered glass vials. PDA J. Pharm. Sci. Technol. 1997, 51 (5), 187–194.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Morrical B. D.,
    2. Goverde M.,
    3. Grausse J.,
    4. Gerwig T.,
    5. Vorgrimler L.,
    6. Morgen R.,
    7. Buttiker J. P.

    Leak testing in parenteral packaging: establishment of direct correlation between helium leak rate measurements and microbial ingress for two different leak types. PDA J. Pharm. Sci. Technol. 2007, 61 (4), 226–236.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Kirsch L. E.,
    2. Nguyen L.,
    3. Moeckly C. S.,
    4. Gerth R.

    Pharmaceutical container/closure integrity. II: The relationship between microbial ingress and helium leak rates in rubber-stoppered glass vials. PDA J. Pharm. Sci. Technol. 1997, 51 (5), 195–202.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Nguyen L. T.,
    2. Muangsiri W.,
    3. Schiere R.,
    4. Guazzo D. K.,
    5. Kirsch L. E.

    Pharmaceutical container/closure integrity. IV: Development of an indirect correlation between vacuum decay leak measurement and microbial ingress. PDA J. Pharm. Sci. Technol. 1999, 53 (4), 211–216.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Keller S. W.

    Determination of the leak size critical to package sterility maintenance. Ph.D Dissertation, Virginia Polytechnic Institute and State University, 1998. Available from https://vtechworks.lib.vt.edu/handle/10919/26690 (accessed July 14, 2018).
18. 18.↵
    1. Yoon S. Y.,
    2. Sagi H.,
    3. Goldhammer C.,
    4. Li L.

    Mass extraction container closure integrity physical testing method development for parenteral container closure systems. PDA J. Pharm. Sci. Technol. 2012, 66 (5), 403–419.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Wolf H.,
    2. Stauffer T.,
    3. Chen S. C.,
    4. Lee Y.,
    5. Forster R.,
    6. Ludzinski M.,
    7. Kamat M.,
    8. Mulhall B.,
    9. Guazzo D. M.

    Vacuum decay container/closure integrity testing technology. Part 2. Comparison to dye ingress tests. PDA J. Pharm. Sci. Technol. 2009, 63 (5), 489–498.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Nieto A.,
    2. Roehl H.,
    3. Brown H.,
    4. Adler M.,
    5. Chalus P.,
    6. Mahler H. C.

    Artificial Leaks in Container Closure Integrity Testing: Nonlinear Finite Element Simulation of Aperture Size Originated by a Copper Wire Sandwiched between the Stopper and the Glass Vial. PDA J. Pharm. Sci. Technol. 2016, 70 (4), 313–324.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Mathaes R.,
    2. Mahler H. C.,
    3. Roggo Y.,
    4. Ovadia R.,
    5. Lam P.,
    6. Stauch O.,
    7. Vogt M.,
    8. Roehl H.,
    9. Huwyler J.,
    10. Mohl S.,
    11. Streubel A.

    Impact of Vial Capping on Residual Seal Force and Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2016, 70 (1), 12–29.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Gooch J. W.

    1. Gooch J. W.

    Hagen-Poiseuille Equation. In Encyclopedic Dictionary of Polymers, Gooch J. W., Ed.; Springer: New York, 2011; p 355.
23. 23.↵
    1. Bialous A. J.,
    2. Peters P. H.,
    3. Stone E. E.

    Leakage Testing Handbook (revised edition) [Online]; National Aeronautics and Space Administration: Pasadena, CA, 1969; Vol. 952. https://archive.org/stream/nasa_techdoc_19690029458/19690029458_djvu.txt (accessed November 10, 2017).
24. 24.
    1. Victor K. G.,
    2. Levac L.,
    3. Timmins M.,
    4. Veale J.

    Method Development for Container Closure Integrity Evaluation via Headspace Gas Ingress by Using Frequency Modulation Spectroscopy. PDA J. Pharm. Sci. Technol. 2017, 71 (6), 429–453.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Peláez S. S.,
    2. Mahler H. C.,
    3. Matter A.,
    4. Koulov A.,
    5. Singh S. K.,
    6. Germershaus O.,
    7. Mathaes R.

    Container Closure Integrity Testing of Prefilled Syringes. J. Pharm. Sci. 2018, 107 (8), 2091–2097.

    OpenUrl
26. 26.↵
    1. Badkar A.,
    2. Wolf A.,
    3. Bohack L.,
    4. Kolhe P.

    Development of biotechnology products in pre-filled syringes: Technical considerations and approaches. AAPS PharmSciTech 2011, 12 (2), 564–572.

    OpenUrlPubMed